New TB drug development @ CSIR-National Chemical Laboratory

Simple item page
dc.date.accessioned2018-06-05T13:10:07Z
dc.date.available2026-02-19T08:53:55Z
dc.date.issued2018-05-04
dc.descriptionThe Pune-based CSIR National Chemical Laboratory (CSIR-NCL), has come up with an anti-tuberculosis (anti-TB) cocrystal drug with improved stability. The research work done by professor AK Nangia and his team at the CSIR-NCL and the School of Chemistry, University of Hyderabad, has cleared the way for development of a stable formulation of 4-FDC (4 drugs fixed dose combination) for curing TB.en_US
dc.identifier.urihttp://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/3936
dc.language.isoenen_US
dc.publisherPune Mirroren_US
dc.subjectTB drugen_US
dc.subjectCrystal Engineeringen_US
dc.subjectCocrystal Drugen_US
dc.subjectIsoniaziden_US
dc.subjectRifampicinen_US
dc.titleNew TB drug development @ CSIR-National Chemical Laboratoryen_US
dc.typeNewspaper Articleen_US
local.division.divisionOrganic Chemistry Divisionen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
TB DRUG @ NCL Pune Mirror _ Friday, May 04, 2018 _ 5.pdf
Size:
92.45 KB
Format:
Adobe Portable Document Format
Description:
New TB Drug @ NCL
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Newspaper Clippings